iCo Therapeutics Inc (MSCL)

1.18
+0.05(+4.42%)
  • Volume:
    900
  • Bid/Ask:
    1.08/1.26
  • Day's Range:
    1.18 - 1.24
  • Type:Equity
  • Market:Canada
  • ISIN:CA80401L3083
  • CUSIP:80401L308

MSCL Overview

Prev. Close
1.13
Day's Range
1.18-1.24
Revenue
70K
Open
1.24
52 wk Range
0.04-1.77
EPS
-2.87
Volume
900
Market Cap
38.61M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
6,316
P/E Ratio
-
Beta
2.43
1-Year Change
2,850%
Shares Outstanding
32,997,613
Next Earnings Date
-
What is your sentiment on iCo Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.

iCo Therapeutics Inc Company Profile

Employees
0
Market
Canada

Satellos Bioscience Inc., a regenerative medicine company, develops therapeutics that stimulate or restore muscle regeneration in severe disorders. Its lead program focuses on the development of a therapeutic for correcting the impaired muscle regenerative process in genetic pediatric disease, duchenne muscular dystrophy (DMD), a genetic disease that involves the mutation and functional disruption of the DMD gene and loss of Dystrophin. The company was incorporated in 2012 and is headquartered in Toronto, Canada.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellSellBuy
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Buy
SummaryStrong SellStrong SellStrong SellStrong SellStrong Buy
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.